Skip to content

Clinical trials

Observational Alzheimer Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Observational Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20121
20131
20142
20164
20181
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universitaire Ziekenhuizen KU Leuven5
Alnylam Pharmaceuticals1
Amoneta Diagnostics SAS1
Brugmann University Hospital1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Murielle Surquin1
Raman Health Technologies, S.L.1
Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1
Universitair Ziekenhuis Brussel1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease14
Cognitive Dysfunction5
Dementia5
Lewy Body Disease3
Cardiomyopathies1
Corticobasal Degeneration1
Diabetic Retinopathy1
Frontotemporal Lobar Degeneration1
Glaucoma1
Heart Failure1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.